Clinical trials of efficacy of systemic acceleration training for the treatment of non-alcoholic fatty liver disease

Clinical trials of efficacy of systemic acceleration training for the treatment of non-alcoholic fatty liver disease - Systemic acceleration training

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007030

Enrollment

Registered

2012-01-23

Start date

2012-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-alcoholic fatty liver disease

Interventions

Systemic acceleration training

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Non-alcoholic fatty liver disease subjects resistant to long-term (more than 3 months) medical treatments, such as diet, exercise, and behavior. 2.Subjects with less than 60% of muscle to total weight in body composition. 3.Subjects less than 80 years old.

Exclusion criteria

Exclusion criteria: 1.Subjects with body weight more than 180 kg. 2.Subjects with any muscle and bone disorders. 3.Subjects with liver cirrhosis (albumin less than 3.5 g/dL, bilirubin more than 3 mg/dl, platelet count less than 10,0000/microL). 4.Subjects with renal dysfunction (serum creatinine more than 1.5 mg/dL). 5.Subjects with past history of ischemic heart disease. 6.Subjects with uncontrolled hypertension (BP more than 140/80 mmHg).

Design outcomes

Primary

Measure	Time frame
Improvement of liver injuries by systemic acceleration training	—

Secondary

Measure	Time frame
Changes in body composition, metabolic function, oxidative stress marker, and hepatic steatosis	—

Countries

Japan

Contacts

Public ContactJunichi Shoda

University of Tsukuba Gastroenterology and Hepatology

shodaj@md.tsukuba.ac.jp029-853-3900

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026